Explore Our Comprehensive Life Sciences Industry Research Reports
U
2024
Carfilzomib, also known as kyprolis, is an anti-cancer medication derived from epoxomicin, which is a naturally occurring product. Epoxomicin is known to inhibit proteasome. Carfilzomib binds to 20-S ...
Report Code : A12647 | Category : Life Sciences
A
2024
The Velcade market study summarizes current market analysis, key ...
Report Code : A177949 | Category : Life Sciences
A
2024
The global Proteasome inhibitors for multiple myeloma market provides an overview of the ...
Report Code : A294091 | Category : Life Sciences
A
2024
Report Summary
Report Code : A294696 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.